Anlotinib as Exploratory Therapy for Platinum-Resistant Ovarian Cancer: A Retrospective Study on Efficacy and Safety.

Autor: Ni, Jing (AUTHOR), Cheng, Xianzhong (AUTHOR), Chen, Jin (AUTHOR), Guo, Wenwen (AUTHOR), Dai, Zhiqin (AUTHOR)
Zdroj: OncoTargets & Therapy. Oct2020, Vol. 13, p9857-9863. 7p.
Databáze: Academic Search Ultimate
Nepřihlášeným uživatelům se plný text nezobrazuje